The impact of statin therapy on the prognosis of hormone receptor-positive breast cancer: a systematic review and meta-analysis - Top-Institutions - MDSpire

The impact of statin therapy on the prognosis of hormone receptor-positive breast cancer: a systematic review and meta-analysis

  • By

  • Xiaowen Ma

  • Yiming Sun

  • Yaqin Qi

  • Hiajiang Qu

  • Feng Zhang

  • June 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Young Women’s Breast Cancer Study
    Young Women’s Breast Cancer Study

    N/A, N/A

    Key Differentiators

    • Oncology

  • #3

    IEO Breast Cancer Cohort
    IEO Breast Cancer Cohort

    Milan, Italy

    Key Differentiators

    • Oncology

  • #4

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Public Health
    • Oncology

  • #5

    Sidney Kimmel Cancer Center
    Sidney Kimmel Cancer Center

    Philadelphia, PA

    Key Differentiators

    • Oncology

Original Source(s)

The impact of statin therapy on the prognosis of hormone receptor-positive breast cancer: a systematic review and meta-analysis

  • by Xiaowen Ma, Yiming Sun, Yaqin Qi, Hiajiang Qu, Feng Zhang

  • June 3, 2026

Related Content

Dana-Farber Research News 05.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from April 16 - 30.

  • May 15, 2026

  • 21 min
Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells

Depression and breast cancer: research progress and prospects from an interdisciplinary perspective